Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Viscera-3: The Natural Ozempic Alternative Now Available on Amazon


News provided by

SANE MD

Jul 15, 2024, 09:00 ET

Share this article

Share toX

Share this article

Share toX


SANE MD is excited to announce that Viscera-3, the revolutionary POSTBiotic supplement, is now available for purchase on Amazon. This groundbreaking product provides a natural and effective alternative to weight loss drugs like Ozempic, offering consumers a safer way to manage weight and improve gut health just in time for summer.

BELLEVUE, Wash., July 15, 2024 /PRNewswire-PRWeb/ -- SANE MD is excited to announce that Viscera-3, the revolutionary POSTBiotic supplement, is now available for purchase on Amazon. This groundbreaking product provides a natural and effective alternative to weight loss drugs like Ozempic, offering consumers a safer way to manage weight and improve gut health just in time for summer.

Viscera-3 is designed to harness the power of the gut microbiome to support weight management, metabolic health, and overall wellness. Unlike traditional weight loss drugs, which can have severe side effects, Viscera-3 works with your body's natural processes to achieve similar results safely and effectively.

Viscera-3 works by utilizing a mechanism similar to popular weight-loss drugs like Ozempic. These drugs, including Wegovy and Mounjaro, target regulatory pathways linked to obesity and diabetes by introducing molecules similar to the natural hormone GLP-1.

Post this

"Many people are turning to drugs like Ozempic, Wegovy, and Mounjaro to lose weight, but these medications often come with a range of side effects that can impact quality of life," says Matthew Olesiak, MD, Chief Medical Director at SANESolution. "Viscera-3 offers a natural, medically proven alternative that supports gut health and weight loss without the risks associated with these drugs."

Viscera-3 leverages the power of POSTBiotics, specifically CoreBiome™ Tributyrin, a patented butyrate supplement that promotes a healthy gut microbiome. This advanced formulation, more effective than sodium butyrate, helps improve digestion, relieves bloating, soothes digestive gas, and supports a balanced metabolism.

"From a medical standpoint, a significant breakthrough in gut and metabolic health would be the ability to deliver POSTBiotics directly into the gut," explains Dr. Olesiak. "Historically, this was impossible because butyrate would be destroyed during digestion before reaching the lower colon. Viscera-3 overcomes this challenge by ensuring the POSTBiotic Butyrate via a Tributyrin supplement formulation survives the digestive process, providing exceptional health benefits."

Viscera-3 works by utilizing a mechanism similar to popular weight-loss drugs like Ozempic. These drugs, including Wegovy and Mounjaro, target regulatory pathways linked to obesity and diabetes by introducing molecules similar to the natural hormone GLP-1. This hormone and others like PYY play a critical role in regulating blood sugar, signaling satiety to the brain, and controlling the digestive process to ensure proper nutrient absorption.

Jonathan Bailor, founder and CEO of SANE MD emphasizes, "Our product, Viscera-3, supports the body's natural production of GLP-1 by nurturing a diverse gut microbiome. This natural process helps regulate appetite and metabolism, providing bloating relief for women along with a safer and more holistic approach to weight management."

While drugs like Ozempic have shown effectiveness in weight loss, they often come with a significant downside. Users commonly report gastrointestinal issues such as nausea, vomiting, diarrhea, and constipation. More severe side effects can include pancreatitis and gastroparesis, conditions that can severely impact one's quality of life. Additionally, the risk of losing lean muscle mass and the potential for rapid weight regain after discontinuing the drug raises concerns about their long-term viability.

"Viscera-3 offers a natural solution that mitigates these risks," says Dr. Olesiak. "By enhancing gut health and promoting the natural production of key hormones, we can help individuals manage their weight without the adverse side effects associated with synthetic drugs."

Recent research has confirmed the benefits of a healthy, balanced microbiome and butyrate, the POSTBiotic in Viscera-3. Here are some of the key benefits:

  • Supports Digestive Health: Reduces painful gas and bloating and promotes regular bowel movements. 1
  • Helps Reduce Inflammation: Helps ease symptoms of inflammatory bowel diseases (IBD) and other gut-related issues. 2, 3, 4
  • Boosts Immune Health: Enhances overall immune function, which is crucial for maintaining health. 5
  • Helps Support Weight Loss: Naturally boosts metabolism and increases insulin sensitivity. 6, 7
  • Improves Brain Function: Supports cognitive health through better gut health. 8, 9

Availability

Viscera-3 is now available for purchase nationwide on Amazon. To learn more about Viscera-3 or to make a purchase, visit: https://a.co/d/0d1GQqPQ

About SANE MD:

SANE MD is a wellness technology and metabolic healing company dedicated to ending the Diabesity (diabetes plus obesity) epidemic. Backed by 1,300 clinical studies and thousands of success stories, SANE MD's metabolic healing framework and model is the only program endorsed by top doctors at the Harvard Medical School, Johns Hopkins, the Mayo Clinic, the Cleveland Clinic, and UCLA, and is the subject of New York Times best-selling books, and award-winning documentaries. Started as a not-for-profit research project by a ten-year Microsoft alum, Jonathan Bailor, SANE MD has transformed into a trusted international wellness brand focused on reversing the most common and devastating modern diseases. Using the latest innovations in biochemical research and a "service-first story-based" marketing approach to reach, lift up, and educate consumer health choices, SANE MD is changing the world of wellness by helping everyone from the underprivileged to the Fortune 500 CEO to regain their "SANEity" one new "SANE" consumer at a time. SANE MD was inducted into Inc. 5000's list of "Fastest-Growing Private Companies in America" for 2020. For more information, visit: https://sanesolution.com/.

Media Contact:

SANE MD, [email protected], +1 6469026690

SOURCE SANE MD

SANE Viscera-3™ Ingredients:

Magnesium (as Magnesium Oxide and Magnesium Bisglycinate Chelate)

Chromium (as Chromium Picolinate)

CoreBiome™ Tributyrin

Pomegranate (Punica granatum) Fruit Extract 40%

Ellagic Acid

Grape (Vitis vinifera) Seed Ext 95% Proanthocyandins

Other ingredients: Gelatin (Capsule), Magnesium Stearate, Silicon Dioxide, Cellulose.

Scientific References

  • Zaleski, A, Banaszkiewicz A, and Walkowiak J. Butyric acid in irritable bowel syndrome. Prz Gastroenterol 8: 350-353, 2013.
  • Bach Knudsen KE, Lærke HN, Hedemann MS. Impact of Diet-Modulated Butyrate Production on Intestinal Barrier Function and Inflammation. Nutrients. 2018 Oct 13;10(10).
  • 7- De Preter V, Arijs I, Windey K, Vanhove W. Impaired butyrate oxidation in ulcerative colitis is due to decreased butyrate uptake and a defect in the oxidation pathway. Inflamm Bowel Dis. 2012 Jun;18(6):1127-36.
  • 8- Hallert C, Björck I, Nyman M. Increasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot study. Inflamm Bowel Dis. 2003 Mar;9(2):116-21.
  • Kelly Cushing, David M Alvarado, Matthew A Ciorba. Butyrate and Mucosal Inflammation: New Scientific Evidence Supports Clinical Observation. Clin Transl Gastroenterol. 2015 Aug; 6(8): e108.
  • Gao Z., Yin J., Zhang J., Ward R. E., Martin R. J., Lefevre M., et al. . (2009). Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58, 1509–1517. 10.2337/db08-1637
  • 14- Gao, Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, Cefalu WT, and Ye J. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58: 1509-1517, 2009.
  • Megan W. Bourassa,a,b Ishraq Alim. Butyrate, Neuroepigenetics and the Gut Microbiome: Can a High Fiber Diet Improve Brain Health? Neurosci Lett. 2016 Jun 20; 625: 56–63.
  • 12- Steliou K1, Boosalis MS, Perrine SP. Butyrate histone deacetylase inhibitors. Biores Open Access. 2012 Aug;1(4):192-8.

Media Contact

Jonathan Bailor, SANE MD, 1 347 979-1735, [email protected] , https://sanesolution.com/ 

SOURCE SANE MD

Modal title

SANE MD Viscera-3
SANE MD Viscera-3
SANE MD Viscera-3

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.